News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24319)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Drug Development
Vifor Pharma Ferroportin Inhibitor Enters Phase-I Clinical Trial
VIT-2763 is an orally administered small molecule developed by Vifor Pharma. I
February 8, 2018
·
3 min read
Catalyst Pharma to Present at Two Upcoming Investor Conferences
The presentation materials for the BIO CEO & Investor conference will be posted at www.catalystpharma.com in the Investor section under Events and Presentations.
February 8, 2018
·
2 min read
Biotech Beach
MediciNova Announces Pricing of Underwritten Public Offering of Common Stock
All of the shares of common stock to be sold in the offering are being offered by MediciNova.
February 8, 2018
·
6 min read
BioMidwest
Gemphire Announces Proposed Public Offering of Common Stock
The offering is subject to market and other conditions.
February 8, 2018
·
4 min read
Biotech Beach
Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative
Upon completion of the comprehensive testing method, each antibody receives a “badge” on the company’s website, called the Advanced Verification Badge.
February 8, 2018
·
2 min read
Business
Contribution from AT&T Supports Science Center Program for High School Students
Representatives from AT&T presented the University City Science Center with $20,000 at the Project Inquiry Student Showcase on February 7, 2018 at the Science Center
February 8, 2018
·
3 min read
Business
Vectura Group plc Notice of Preliminary Results
Vectura Group plans to announce its Preliminary Results for the 12 months ended 31 December 2017 on Wednesday 21 March 2018.
February 8, 2018
·
1 min read
Business
Nestlé and Nuritas to Work Together on Discovery of Food-Derived Bioactive Peptides Through Artificial Intelligence
Nestle and Nuritas have entered into a collaboration aiming at discovering bioactive peptide networks within specific target areas of significant value.
February 8, 2018
·
1 min read
Business
Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences
Management will conduct a conference call and audio webcast on Wednesday, February 14, 2018 at 8:30 a.m. Eastern Time to discuss these results.
February 8, 2018
·
1 min read
Deals
Massachusetts General Hospital Joins Panfam-1 Prospective Study for the Early Detection of Pancreatic Cancer in Familiar Risk Groups
The aim is to prove the overall healthcare benefits of testing hereditary pancreatic cancer patients.
February 8, 2018
·
3 min read
Previous
9 of 15
Next